Expert Discusses How DMT Differs From Other Psychedelic Medicines
Source : https://www.pharmacytimes.com/view/expert-discusses-how-dmt-differs-from-other-psychedelic-medicines
Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discussed DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments. She spoke...
Salk researchers find a new route for regulating blood sugar levels independent of insulin - Salk Institute for Biological Studies
LA JOLLA-The discovery of insulin 100 years ago opened a door that would lead to life and hope for millions of people with diabetes. Ever since then, insulin, produced in...
Finding the PDE4 pathway opens new opportunities for drug discovery and basic research focused on high blood glucose (hyperglycemia) and insulin resistance. The scientists are eager to investigate the possibility of modifying FGF1 to improve PDE4 activity. Another route is targeting multiple points in the signaling pathway before PDE4 is...
COVID-19 vaccination associated with a small, temporary increase in menstrual cycle length, suggests NIH-funded study
Women receiving one dose of a COVID-19 vaccine during a single menstrual cycle had an increase in cycle length of nearly one day, compared to unvaccinated women, according to a...
A subgroup of app users who received two vaccine doses in the same menstrual cycle (358 users) had a larger average increase in cycle length of two days. However, this change appears to decrease in subsequent cycles, indicating that the menstrual changes likely are temporary. The authors added that the International Federation of Gynecology and...
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study
Source : https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003874
Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Anne Katrine Bjørkholt Sørensen, Palle Valentiner-Branth, Hanne-Dorthe Emborg Subject Areas For more information about PLOS Subject...
/>
Conclusions: In this study, we observed a large reduction in the risk of SARS-CoV-2 infection when combining the ChAdOx1 and an mRNA vaccine, compared with unvaccinated individuals.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Source : https://www.nejm.org/doi/full/10.1056/NEJMoa2116846
Our apologies. An error occurred while setting your user cookie. Please set your browser to accept cookies to continue. NEJM.org uses cookies to improve performance by remembering your session ID...
CONCLUSIONS: Among nonhospitalized patients who were at high risk for Covid-19 progression, a 3-day course of remdesivir had an acceptable safety profile and resulted in an 87% lower risk of hospitalization or death than placebo.